Search research articles
Contact Us
Filters
Showing results (21-30 of 111) with videos related to
Page
of 12
Sort By:
Oncogene Research
|
September 1, 1987
Human cellular fps/fes cDNA rescued via retroviral shuttle vector encodes myeloid cell NCP92 and has transforming potential
R A Feldman, W C Vass, P E Tambourin
Oncogene Research
|
January 1, 1990
Selective potentiation of c-fps/fes transforming activity by a phosphatase inhibitor
R A Feldman, D R Lowy, W C Vass
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1984
Identification of a second transforming region in bovine papillomavirus DNA
J T Schiller, W C Vass, D R Lowy
The Journal of Biological Chemistry
|
August 18, 1995
SHC and GRB-2 are constitutively by an epidermal growth factor receptor with a point mutation in the transmembrane domain
M Miloso, M Mazzotti, W C Vass, et al.
Journal of Cataract and Refractive Surgery
|
November 18, 1998
Comparative study of corneal topographic changes after 3.0 mm beveled and hinged clear corneal incisions
C Vass, R Menapace, G Rainer, et al.
Journal of Glaucoma
|
February 1, 2002
Activity of dissolved mitomycin C after different methods of long-term storage
M Georgopoulos, C Vass, Z Vatanparast, et al.
Journal of Cataract and Refractive Surgery
|
April 1, 1997
Surgically induced astigmatism following a 4.0 mm sclerocorneal valve incision
G Rainer, R Menapace, C Vass, et al.
Journal of Cataract and Refractive Surgery
|
April 1, 1996
Batch-by-batch analysis of topographic changes induced by sutured and sutureless clear corneal incisions
C Vass, R Menapace, M Amon, et al.
Experimental Eye Research
|
June 28, 2000
Intrascleral concentration vs depth profile of mitomycin-C after episcleral application: impact of applied concentration and volume of mitomycin-C solution
C Vass, M Georgopoulos, I el Menyawi, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
April 28, 2001
Impact of Mitomycin-C application time on the scleral Mitomycin-C concentration
C Vass, M Georgopoulos, I El Menyawi, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 111) with videos related to
Sort By:
Page
of 12
Oncogene Research
|
September 1, 1987
Human cellular fps/fes cDNA rescued via retroviral shuttle vector encodes myeloid cell NCP92 and has transforming potential
R A Feldman, W C Vass, P E Tambourin
Oncogene Research
|
January 1, 1990
Selective potentiation of c-fps/fes transforming activity by a phosphatase inhibitor
R A Feldman, D R Lowy, W C Vass
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1984
Identification of a second transforming region in bovine papillomavirus DNA
J T Schiller, W C Vass, D R Lowy
The Journal of Biological Chemistry
|
August 18, 1995
SHC and GRB-2 are constitutively by an epidermal growth factor receptor with a point mutation in the transmembrane domain
M Miloso, M Mazzotti, W C Vass, et al.
Journal of Cataract and Refractive Surgery
|
November 18, 1998
Comparative study of corneal topographic changes after 3.0 mm beveled and hinged clear corneal incisions
C Vass, R Menapace, G Rainer, et al.
Journal of Glaucoma
|
February 1, 2002
Activity of dissolved mitomycin C after different methods of long-term storage
M Georgopoulos, C Vass, Z Vatanparast, et al.
Journal of Cataract and Refractive Surgery
|
April 1, 1997
Surgically induced astigmatism following a 4.0 mm sclerocorneal valve incision
G Rainer, R Menapace, C Vass, et al.
Journal of Cataract and Refractive Surgery
|
April 1, 1996
Batch-by-batch analysis of topographic changes induced by sutured and sutureless clear corneal incisions
C Vass, R Menapace, M Amon, et al.
Experimental Eye Research
|
June 28, 2000
Intrascleral concentration vs depth profile of mitomycin-C after episcleral application: impact of applied concentration and volume of mitomycin-C solution
C Vass, M Georgopoulos, I el Menyawi, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
April 28, 2001
Impact of Mitomycin-C application time on the scleral Mitomycin-C concentration
C Vass, M Georgopoulos, I El Menyawi, et al.
Page
of 12